These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2494243

  • 1. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M.
    J Am Coll Cardiol; 1989 Mar 15; 13(4):904-10. PubMed ID: 2494243
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
    Chimienti M, Li Bergolis M, Moizi M, Salerno JA.
    J Am Coll Cardiol; 1989 Oct 15; 14(4):992-8. PubMed ID: 2507613
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV, Jackman WM, Akhtar M, Rinkenberger RL, Friday KJ, Dougherty AH, Tchou P, Yeung-Lai-Wah JA.
    Am J Cardiol; 1988 Dec 20; 62(19):31L-36L. PubMed ID: 3144165
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN, Klein GJ, Rinkenberger RL, Heger JJ, Naccarelli GV, Zipes DP.
    Circulation; 1984 Feb 20; 69(2):278-87. PubMed ID: 6418407
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atrioventricular nodal reentrant tachycardia in patients with ventriculo-atrial conduction block.
    Kerr CR, Murdock CJ, Yeung-Lai-Wah JA.
    Can J Cardiol; 1994 Mar 20; 10(2):255-8. PubMed ID: 8143227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I, Scheinman MM, Herre JM, Sharkey H, Griffin JC.
    J Am Coll Cardiol; 1990 Dec 20; 16(7):1649-55. PubMed ID: 2123908
    [Abstract] [Full Text] [Related]

  • 15. Atypical forms of supraventricular tachycardia due to atrioventricular node reentry in children after radiofrequency modification of slow pathway conduction.
    Silka MJ, Kron J, Park JK, Halperin BD, McAnulty JH.
    J Am Coll Cardiol; 1994 May 20; 23(6):1363-9. PubMed ID: 8176094
    [Abstract] [Full Text] [Related]

  • 16. AV nodal reentrant tachycardia using three different AV nodal pathways.
    Kühlkamp V, Haasis R, Seipel L.
    Eur Heart J; 1990 Sep 20; 11(9):857-62. PubMed ID: 2226514
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
    Kunze KP, Kuck KH, Schlüter M, Kuch B, Bleifeld W.
    Am J Cardiol; 1984 Aug 01; 54(3):323-9. PubMed ID: 6431796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.